302 related articles for article (PubMed ID: 30930172)
1. Systemic treatment with resveratrol alleviates adjuvant arthritis-interstitial lung disease in rats via modulation of JAK/STAT/RANKL signaling pathway.
Yang G; Lyu L; Wang X; Bao L; Lyu B; Lin Z
Pulm Pharmacol Ther; 2019 Jun; 56():69-74. PubMed ID: 30930172
[TBL] [Abstract][Full Text] [Related]
2. Nicorandil and theophylline can protect experimental rats against complete Freund's adjuvant-induced rheumatoid arthritis through modulation of JAK/STAT/RANKL signaling pathway.
Gaafar AGA; Messiha BAS; Abdelkafy AML
Eur J Pharmacol; 2018 Mar; 822():177-185. PubMed ID: 29337196
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol attenuates inflammation and fibrosis in rheumatoid arthritis-associated interstitial lung disease via the AKT/TMEM175 pathway.
Liu N; Fan X; Shao Y; Chen S; Wang T; Yao T; Chen X
J Transl Med; 2024 May; 22(1):457. PubMed ID: 38745204
[TBL] [Abstract][Full Text] [Related]
4. Genkwanin ameliorates adjuvant-induced arthritis in rats through inhibiting JAK/STAT and NF-κB signaling pathways.
Bao Y; Sun YW; Ji J; Gan L; Zhang CF; Wang CZ; Yuan CS
Phytomedicine; 2019 Oct; 63():153036. PubMed ID: 31401534
[TBL] [Abstract][Full Text] [Related]
5. "Cerastes snake venom as a promising approach in the management of complete Freund's adjuvant-induced rheumatoid arthritis in rats: Involvement of RANKL and JAK/STAT pathway".
Soliman NS; Kandeil MA; Khalaf MM
J Ethnopharmacol; 2023 Oct; 314():116577. PubMed ID: 37178980
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Potential of Janus Kinase Inhibitors for the Management of Interstitial Lung Disease.
Huo R; Guo Q; Hu J; Li N; Gao R; Mi L; Zhang Z; Liu H; Guo Z; Zhao H; Zhang L; Xu K
Drug Des Devel Ther; 2022; 16():991-998. PubMed ID: 35400994
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol protects hippocampal neurons against cerebral ischemia-reperfusion injury via modulating JAK/ERK/STAT signaling pathway in rats.
Chang C; Zhao Y; Song G; She K
J Neuroimmunol; 2018 Feb; 315():9-14. PubMed ID: 29306408
[TBL] [Abstract][Full Text] [Related]
8. The rationale for targeting the JAK/STAT pathway in scleroderma-associated interstitial lung disease.
Talotta R
Immunotherapy; 2021 Feb; 13(3):241-256. PubMed ID: 33410346
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol Ameliorates Fibrosis in Rheumatoid Arthritis-Associated Interstitial Lung Disease via the Autophagy-Lysosome Pathway.
Bao L; Ye J; Liu N; Shao Y; Li W; Fan X; Zhao D; Wang H; Chen X
Molecules; 2022 Dec; 27(23):. PubMed ID: 36500562
[TBL] [Abstract][Full Text] [Related]
10. Advance in bone destruction participated by JAK/STAT in rheumatoid arthritis and therapeutic effect of JAK/STAT inhibitors.
Hu L; Liu R; Zhang L
Int Immunopharmacol; 2022 Oct; 111():109095. PubMed ID: 35926270
[TBL] [Abstract][Full Text] [Related]
11. Sitagliptin and tofacitinib ameliorate adjuvant induced arthritis via modulating the cross talk between JAK/STAT and TLR-4/NF-κB signaling pathways.
Ibrahim SSA; Salama MA; Selima E; Shehata RR
Life Sci; 2020 Nov; 260():118261. PubMed ID: 32795539
[TBL] [Abstract][Full Text] [Related]
12. Targeting inflammation and redox perturbations by lisinopril mitigates Freund's adjuvant-induced arthritis in rats: role of JAK-2/STAT-3/RANKL axis, MMPs, and VEGF.
Arab HH; Abd El-Aal SA; Ashour AM; El-Sheikh AAK; Al Khabbaz HJ; Arafa EA; Mahmoud AM; Kabel AM
Inflammopharmacology; 2022 Oct; 30(5):1909-1926. PubMed ID: 35764864
[TBL] [Abstract][Full Text] [Related]
13. Investigating the therapeutic potential of sinomenine in rheumatoid arthritis: anti-inflammatory, antioxidant, and immunomodulatory mechanisms.
Li J; Cao J; Chen Q; Liu D; Li R
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3945-3958. PubMed ID: 37991542
[TBL] [Abstract][Full Text] [Related]
14. Phytochemicals targeting JAK/STAT pathway in the treatment of rheumatoid arthritis: Is there a future?
Kour G; Choudhary R; Anjum S; Bhagat A; Bajaj BK; Ahmed Z
Biochem Pharmacol; 2022 Mar; 197():114929. PubMed ID: 35065024
[TBL] [Abstract][Full Text] [Related]
15. Allylpyrocatechol Attenuates Collagen-Induced Arthritis via Attenuation of Oxidative Stress Secondary to Modulation of the MAPK, JAK/STAT, and Nrf2/HO-1 Pathways.
De S; Manna A; Kundu S; De Sarkar S; Chatterjee U; Sen T; Chattopadhyay S; Chatterjee M
J Pharmacol Exp Ther; 2017 Feb; 360(2):249-259. PubMed ID: 27856937
[TBL] [Abstract][Full Text] [Related]
16. JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production.
LaBranche TP; Jesson MI; Radi ZA; Storer CE; Guzova JA; Bonar SL; Thompson JM; Happa FA; Stewart ZS; Zhan Y; Bollinger CS; Bansal PN; Wellen JW; Wilkie DP; Bailey SA; Symanowicz PT; Hegen M; Head RD; Kishore N; Mbalaviele G; Meyer DM
Arthritis Rheum; 2012 Nov; 64(11):3531-42. PubMed ID: 22899318
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a Rat Adjuvant Arthritis-Interstitial Lung Disease Model.
Song LN; Kong XD; Wang HJ; Zhan LB
Biomed Res Int; 2016; 2016():2970783. PubMed ID: 26881215
[TBL] [Abstract][Full Text] [Related]
18. A novel therapeutic approach targeting rheumatoid arthritis by combined administration of morin, a dietary flavanol and non-steroidal anti-inflammatory drug indomethacin with reference to pro-inflammatory cytokines, inflammatory enzymes, RANKL and transcription factors.
Sultana F; Rasool M
Chem Biol Interact; 2015 Mar; 230():58-70. PubMed ID: 25698669
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory and osteoprotective effects of Chikusetsusaponin Ⅳa on rheumatoid arthritis via the JAK/STAT signaling pathway.
Guo X; Ji J; Zhang J; Hou X; Fu X; Luo Y; Mei Z; Feng Z
Phytomedicine; 2021 Dec; 93():153801. PubMed ID: 34758437
[TBL] [Abstract][Full Text] [Related]
20. Etiology and Pathogenesis of Rheumatoid Arthritis-Interstitial Lung Disease.
Kim Y; Yang HI; Kim KS
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
